Hershey says it will shift back to classic recipe for all Reese's products after criticism

Hershey will revert to classic milk and dark chocolate recipes for all Reese's products starting next year and will move items currently using a lower-chocolate coating (e.g., mini Easter eggs) back to classic recipes by 2027. The company will also transition to natural colors, make Kit-Kat creamier, and increase R&D funding by 25% next year; the actions follow public criticism from the founder's grandson and elevated cocoa prices that prompted prior ingredient changes. These measures are primarily reputational and product-quality focused and should help restore brand trust but are unlikely to materially change Hershey's near-term financial outlook.

Analysis

Restoring higher-quality formulations is a strategic signal that management is prioritizing brand equity over near-term cost savings; that tradeoff typically compresses gross margin by a few dozen-to-a few hundred basis points in the first 2-6 quarters but preserves pricing power and household penetration over a 2-5 year window. The announced R&D step-up (material on its own) increases fixed costs this fiscal year but widens optionality for premium SKUs and line extensions—an investment that can lift ASPs and marketing ROI if new recipes generate repeat purchase rates above 5-8% vs baseline.

On the supply side, any industry-wide reversion to more chocolate-heavy coatings raises incremental cocoa demand and quality-differentiated sourcing needs: expect shorter-term spot cocoa volatility, more hedging activity by manufacturers, and upward pressure on specialty couverture prices that feed into co-manufacturers and private-label margins. Retail shelf dynamics will also tilt toward proven flagship SKUs (benefitting national brands and premium suppliers) and away from low-cost coated novelties, shifting promotional cadence and slotting fees over the next 4-12 months.

Key risks and catalysts: social-media-driven reputational shocks can create immediate selloffs (days–weeks) but are reversible with transparent quality metrics and sales data (quarters). Reversal triggers include a sustained cocoa price drop, failure of new recipes to measurably lift repeat purchase, or evidence that higher input costs cannot be passed through to consumers; watch upcoming quarterly guidance, SKU-level sell-through, and cocoa futures positions as 30–90 day lead indicators.

Key Decisions for Investors

• Buy HSY equity (6–12 month horizon): target +15% upside vs a 10% stop. Rationale: brand restoration should support multiple expansion as premium SKU mix and pricing power recover; key risk is margin pressure from higher cocoa and elevated R&D spend in the next two quarters.
• Pair trade — Long HSY / Short MDLZ (equal notional, 6–12 months): asymmetric upside if HSY captures reconversion loyalty in the U.S. while MDLZ’s global exposure mutes domestic premium capture. Risk: sector-wide commodity moves lift both names; use cocoa futures/options as hedge.
• Buy ICE cocoa (CC) 3–12 month call spread to express modest bullishness on specialty cocoa demand: long 6–9 month calls and short higher-strike calls to cap premium paid. Reward: supply-tightening from recipe reversions would spike spot cocoa; tail risk is demand destruction or supply relief.
• Buy HSY 9–12 month call options (delta ~0.35–0.45) as a convex play on re-rating around the next two quarterly updates: limited downside (premium) with leveraged upside if sales/mix beat. Keep notional size <2% of equity allocation to limit vega/time decay exposure.